Norway vs United States: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Norway
95.0%
in 2025
United States
95.0%
in 2025
Norway rank
29th
United States rank
29th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Norway
- United States
How they compare
Norway currently reports 95.0% against 95.0% in United States, a difference of 0.0%.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was Norway ahead.
Norway ranks 29th and United States ranks 29th of 194 countries.
Across the 3 decades both report, Norway averaged higher in 2 and United States in 1.
Head to head by decade
| Decade | Norway | United States | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.5% | 86.2% | 5.3% | Norway |
| 2010s | 92.6% | 92.3% | 0.3% | Norway |
| 2020s | 94.5% | 95.0% | 0.5% | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Norway or United States?
- Norway, at 95.0% against 95.0% in United States as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Norway and United States?
- 0.0%, with Norway ahead.
- How many years of comparable data are there for Norway and United States?
- 26 years are reported by both, from 2000 to 2025.
- How do Norway and United States rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Norway ranks 29th and United States ranks 29th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.